Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals Announces Collaboration with Massachusetts General Hospital in Skin Cancer Study
28 nov. 2023 10h00 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals Inc, a Vancouver based biopharmaceutical company with a focus on skin disease, is excited to announce that...
immunocore-logo-2018
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
07 nov. 2023 07h00 HE | Immunocore Holdings Limited
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update KIMMTRAK net revenues of £49.7 million ($60.7 million) in Q3 2023, maintaining strong momentum in major...
SNS-INSIDER-300X300.jpg
Skin Cancer Treatment Market to Surpass USD 18.06 Billion by 2030 Driven by Rising Incidence of Skin Cancer and Globalization of Healthcare | Research by SNS Insider
16 oct. 2023 09h05 HE | SNS Insider pvt ltd
Pune, Oct. 16, 2023 (GLOBE NEWSWIRE) -- “The Skin Cancer Treatment Market, as per the SNS Insider report, achieved a value of USD 9.98 Billion and is projected to attain USD 18.06 Billion by 2030,...
MicrosoftTeams-image (5).png
Mineral Sunscreen Market Revenue to Reach USD 1.6 Bn by 2031, growing at a CAGR of 5.4%: Reveals TMR Study
08 mai 2023 12h30 HE | Transparency Market Research
Wilmington, Delaware, United States, May 08, 2023 (GLOBE NEWSWIRE) -- The global mineral sunscreen market was valued at USD 960.0 Mn in 2021 and is anticipated to reach USD 1.6 Bn by 2031, expanding...
CLINUVEL's CYACÊLLE
CLINUVEL Launches CYACÊLLE, Next Generation Solar Care
28 févr. 2023 18h58 HE | Clinuvel Pharmaceuticals Limited
UV, HEV protection for individuals at high risk of photoageing and skin cancer MELBOURNE, Australia, March 01, 2023 (GLOBE NEWSWIRE) -- CLINUVEL (ASX: CUV) (Börse Frankfurt: UR9) (ADR Level...
Full Latin without Latin logo.png
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals
01 févr. 2023 19h14 HE | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Results released today from a clinical study have shown that the drug afamelanotide can reduce critical skin damage caused by ultraviolet (UV)...
Full Latin without Latin logo.png
CLINUVEL Trial Results Show Drug Reduces DNA Damage
15 janv. 2023 18h23 HE | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair disorder show that a new drug – afamelanotide – may be able to reduce the development of...
logo_tau.png
Alpha Tau Medical Announces Third Quarter 2022 Financial Results and Provides Corporate Update
22 nov. 2022 16h02 HE | Alpha Tau Medical Ltd.
JERUSALEM, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), ("Alpha Tau" or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha...
Skinopathy dark logo (1).png
The GetSkinHelp WalkING Clinic will be travelling through the streets of Downtown Toronto and help people get the medical attention they need and are waiting for
14 nov. 2022 07h07 HE | Skinopathy
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Skinopathy, the company behind GetSkinHelp, are helping people avoid months of waiting thanks to The GetSkinHelp WalkING Clinic which will bring the doctor...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals, Inc. reports positive preclinical data in melanoma and squamous cell carcinoma, initiates a program aimed at advancing topical therapies for skin cancer to the clinic
12 oct. 2022 10h00 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy aging, has...